Saudi Arabia vs Sierra Leone: Tuberculosis treatment success rate by type
Saudi Arabia
92
in 2023
Sierra Leone
92
in 2023
Saudi Arabia rank
30th
Sierra Leone rank
30th
Tuberculosis treatment success rate by type over time
- Saudi Arabia
- Sierra Leone
How they compare
Saudi Arabia currently reports 92 against 92 in Sierra Leone, a difference of 0.
The two have swapped places 2 times across 27 shared years of data; in 1996 it was Sierra Leone ahead.
Saudi Arabia ranks 30th and Sierra Leone ranks 30th of 194 countries.
Sierra Leone has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 61 | 76 | 15 | Sierra Leone |
| 2000s | 71.5 | 82.9 | 11.4 | Sierra Leone |
| 2010s | 72.1 | 87.9 | 15.8 | Sierra Leone |
| 2020s | 90.5 | 91 | 0.5 | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Saudi Arabia or Sierra Leone?
- Saudi Arabia, at 92 against 92 in Sierra Leone as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Saudi Arabia and Sierra Leone?
- 0, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Sierra Leone?
- 27 years are reported by both, from 1996 to 2023.
- How do Saudi Arabia and Sierra Leone rank globally for tuberculosis treatment success rate by type?
- Saudi Arabia ranks 30th and Sierra Leone ranks 30th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.